Original Antigenic Sin and Respiratory Syncytial Virus Vaccines

被引:9
|
作者
Tripp, Ralph A. [1 ]
Power, Ultan F. [2 ]
机构
[1] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA
[2] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, Belfast BT9 7BL, Antrim, North Ireland
基金
英国生物技术与生命科学研究理事会;
关键词
original antigenic sin; OAS; RSV; vaccines; vaccine effectiveness; VE; immunological memory; PULMONARY INFLAMMATORY RESPONSE; COTTON RATS; PROTECTIVE EFFICACY; BBG2NA VACCINE; FUSION PROTEIN; RSV; IMMUNIZATION; DISEASE; CHALLENGE; INFECTION;
D O I
10.3390/vaccines7030107
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The original antigenic sin (OAS) theory considers the outcome of the first encounter with an antigen. It favors a memory response to the original antigen upon exposure to a similar or related antigen, and includes both positive and negative impacts of past exposure on the memory response to challenge, and, in particular, on vaccine efficacy. This phenomenon is closely linked with imprinting and the hierarchical nature of immune responses to previously encountered antigens. The focus of this commentary centers on the potential role of OAS or immunological imprinting on respiratory syncytial virus memory responses.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] The road to approved vaccines for respiratory syncytial virus
    Ruckwardt, Tracy J.
    NPJ VACCINES, 2023, 8 (01)
  • [32] Clinical experience with respiratory syncytial virus vaccines
    Piedra, PA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (02) : S94 - S99
  • [33] Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
    Topalidou, Xanthippi
    Kalergis, Alexis M.
    Papazisis, Georgios
    PATHOGENS, 2023, 12 (10):
  • [34] ANTIGENIC STRUCTURE OF THE FUSION GLYCOPROTEIN OF RESPIRATORY SYNCYTIAL VIRUS
    PARADISO, PR
    HU, B
    HILDRETH, S
    MARTIN, A
    ARUMUGHAM, R
    IMMUNOBIOLOGY OF PROTEINS AND PEPTIDES V : VACCINES: MECHANISMS, DESIGN AND APPLICATIONS, 1989, 251 : 273 - 278
  • [35] ANTIGENIC VARIATIONS OF RESPIRATORY SYNCYTIAL VIRUS IN RECURRENT INFECTIONS
    POTHIER, P
    GHIM, S
    BOUR, TB
    GOUYON, JB
    DAUVERGNE, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (02) : 212 - 212
  • [36] The Design of Vaccines Based on the Shielding of Antigenic Site o of a Respiratory Syncytial Virus Fusion Protein Immunogen
    Frey, Steven J.
    Varner, Chad
    Arsiwala, Ammar
    Currier, Michael G.
    Moore, Martin L.
    Kane, Ravi S.
    ADVANCED HEALTHCARE MATERIALS, 2021, 10 (04)
  • [37] Antigenic and genetic variation in human respiratory syncytial virus
    Wertz, GW
    Moudy, RM
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (01) : S19 - S23
  • [38] Development of parainfluenza virus and respiratory syncytial virus subunit vaccines
    Ewasyshyn, M
    Cates, G
    Jackson, G
    Symington, A
    Scollard, N
    Du, RP
    Klein, M
    VACCINE DESIGN: THE ROLE OF CYTOKINE NETWORKS, 1997, 293 : 51 - 58
  • [39] Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines
    Durbin, AP
    Karron, RA
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) : 1668 - 1677
  • [40] An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection
    Midgley, Claire M.
    Bajwa-Joseph, Martha
    Vasanawathana, Sirijitt
    Limpitikul, Wannee
    Wills, Bridget
    Flanagan, Aleksandra
    Waiyaiya, Emily
    Tran, Hai Bac
    Cowper, Alison E.
    Chotiyarnwon, Pojchong
    Grimes, Jonathan M.
    Yoksan, Sutee
    Malasit, Prida
    Simmons, Cameron P.
    Mongkolsapaya, Juthathip
    Screaton, Gavin R.
    JOURNAL OF VIROLOGY, 2011, 85 (01) : 410 - 421